Present and future of coronary risk assessment.
Computed tomography
Coronary risk assessment
Subclinical atherosclerosis
Journal
European heart journal supplements : journal of the European Society of Cardiology
ISSN: 1520-765X
Titre abrégé: Eur Heart J Suppl
Pays: England
ID NLM: 100886647
Informations de publication
Date de publication:
Oct 2021
Oct 2021
Historique:
entrez:
15
10
2021
pubmed:
16
10
2021
medline:
16
10
2021
Statut:
epublish
Résumé
The search for subclinical atherosclerosis is carried out in several arterial districts using ultrasonography and computed tomography (CT). Coronary calcium assessed by computerized tomography (calcium score) is a well-validated marker of atherosclerosis and able to correlate with the extent of coronary artery disease and the risk of cardiovascular events. The evaluation of carotid atherosclerosis by ultrasonography is a technically simple and low-cost solution. However, the literature does not provide a sufficient number of evidence to clarify the clinical impact of carotid atherosclerosis and in particular the risk of developing cardiac events. According to the researchers of the Progression of Early Subclinical Atherosclerosis (PESA) study, subclinical atherosclerosis research should preferably be carried out in the femoral district, which is more easily affected by atherosclerosis. Pending the data from the PESA study, which will better clarify the role of ultrasound applied in non-coronary districts, the coronary calcifications seems to be a reasonable solution. It is possible that in the future imaging techniques (CT-PET) capable of studying the extent and functional status of coronary atherosclerosis will further improve the identification of the risk of cardiovascular events.
Identifiants
pubmed: 34650370
doi: 10.1093/eurheartj/suab106
pii: suab106
pmc: PMC8503411
doi:
Types de publication
Journal Article
Langues
eng
Pagination
E123-E127Informations de copyright
Published on behalf of the European Society of Cardiology. © The Author(s) 2021.
Références
J Am Coll Cardiol. 2017 Apr 11;69(14):1774-1791
pubmed: 28385306
Am J Cardiol. 2010 Aug 1;106(3):342-7
pubmed: 20643243
Cerebrovasc Dis. 2004;18(4):346-9
pubmed: 15523176
Int J Cardiol. 2002 Mar;82(3):297-8; author reply 299
pubmed: 11911919
N Engl J Med. 2016 Dec 15;375(24):2349-2358
pubmed: 27959714
Ann Intern Med. 1998 Feb 15;128(4):262-9
pubmed: 9471928
Heart. 2012 Feb;98(3):177-84
pubmed: 22095617
Eur Heart J. 2020 Jan 14;41(3):383-391
pubmed: 31504405
Lancet. 2013 Feb 23;381(9867):629-38
pubmed: 23439102
J Am Coll Cardiol. 2007 Jan 23;49(3):378-402
pubmed: 17239724
Arterioscler Thromb Vasc Biol. 2016 Jun;36(6):1286-92
pubmed: 27102964
Circulation. 2002 Dec 17;106(25):3143-421
pubmed: 12485966
JAMA. 2012 Aug 22;308(8):796-803
pubmed: 22910757
Arch Intern Med. 2004 Jun 28;164(12):1285-92
pubmed: 15226161
Am J Cardiol. 2002 Mar 15;89(6):757-60
pubmed: 11897220
J Am Coll Cardiol. 2001 Feb;37(2):451-7
pubmed: 11216962
JAMA. 2004 Jan 14;291(2):210-5
pubmed: 14722147
Circulation. 1996 Sep 1;94(5):1175-92
pubmed: 8790070
N Engl J Med. 2007 Aug 2;357(5):443-53
pubmed: 17634449
J Am Coll Cardiol. 2010 Apr 13;55(15):1600-7
pubmed: 20378078
J Am Heart Assoc. 2020 Feb 4;9(3):e014795
pubmed: 31983321
J Am Coll Cardiol. 2009 Jun 30;54(1):49-57
pubmed: 19555840
Arterioscler Thromb Vasc Biol. 1999 Jun;19(6):1484-90
pubmed: 10364079
Stroke. 1997 Mar;28(3):518-25
pubmed: 9056605
Lancet. 2014 Feb 22;383(9918):705-13
pubmed: 24224999
J Am Coll Cardiol. 2011 May 3;57(18):1838-45
pubmed: 21527159
J Am Coll Cardiol. 2015 Mar 24;65(11):1065-74
pubmed: 25790876
Atherosclerosis. 1988 Apr;70(3):253-61
pubmed: 3284536
Circulation. 2015 Jun 16;131(24):2104-13
pubmed: 25882487
Eur Heart J Suppl. 2020 Jun;22(Suppl E):E87-E90
pubmed: 32523447
J Am Coll Cardiol. 2001 May;37(6):1506-11
pubmed: 11345357
Eur Heart J. 2020 Jan 1;41(1):111-188
pubmed: 31504418
Circulation. 1997 Sep 2;96(5):1432-7
pubmed: 9315528